发明名称 CONFORMATIONALLY CONSTRAINED BACKBONE-CYCLIZED PEPTIDE ANALOG
摘要 <p><P>PROBLEM TO BE SOLVED: To provide a novel backbone-cyclized analog comprising a peptide sequence containing at least two building units. <P>SOLUTION: The backbone-cyclized peptide analog is formed by means of bridging groups bonded via the alpha nitrogen atoms of an amino acid derivative to provide novel nonpeptidic linkages. The novel building units are N<SP>α</SP>/(ω-functionalized) amino acids constructed to include a spacer and a terminal functional group. One or more of these N<SP>α</SP>/(ω-functionalized) amino acids are incorporated into a peptide sequence, preferably during solid phase peptide synthesis. The reactive terminal functional groups are protected by specific protecting groups that can be selectively removed to effect either backbone-to-backbone or backbone-to-side chain cyclizations. The peptide analog is exemplified by a backbone-cyclized bradykinin antagonist having biological activity. A further embodiment is somatostatin analog having one or two ring structures involving main chain cyclization. <P>COPYRIGHT: (C)2006,JPO&NCIPI</p>
申请公布号 JP2006077017(A) 申请公布日期 2006.03.23
申请号 JP20050267462 申请日期 2005.09.14
申请人 DEVELOGEN ISRAEL LTD;YISSUM RESEARCH DEVELOPMENT CO OF THE HEBREW UNIV 发明人 GILON CHAIM;EREN DORON;ZELTSER IRINA;SERI-LEVY ALON;BITAN GAL;MULLER DAN
分类号 A61K38/22;C07K7/64;A61K38/00;A61K38/04;A61K38/17;A61P1/04;A61P1/12;A61P9/02;A61P11/06;A61P29/00;A61P31/04;A61P35/00;A61P37/08;C07C271/20;C07C271/22;C07C323/25;C07K1/08;C07K7/02;C07K7/18;C07K7/56;C07K14/00;C07K14/655;G01R31/3185 主分类号 A61K38/22
代理机构 代理人
主权项
地址